• Latest Posts

BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry

Replay receives $1.5M grant for hypoimmunogenic technology platform

Growth in UK cell and gene therapy sector continues

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

In Depth 20 Oct 2022

Opportunities and challenges for cell and gene therapy investments

Agreement to take advantage of stem cells from first teeth


Xcell Biosciences and aCGT Vector pushing ahead with cell and gene therapies

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

AmplifyBio acquires PACT Pharma assets

Human cells can now help scientists accelerate cure for neurodegenerative diseases

Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies

Interview 27 Sep 2022

Natural killer cells: a thriving frontier in allogeneic cell therapy